LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Timepoint Timepoint Unit Mean Total Cell Count Before Treatment Mean Total Cell Count After Treatment Mean Total Control Cell Count Mean Relative Cell Count Mean Normalized Growth Rate Inhibition Value
MCF7 Linifanib
0.04
uM
LJP6
 72
hr
 1235 4787 4056 1.1804 1.2033
SK-BR-3 PD173074
0.04
uM
LJP6
 72
hr
 1476 4309 3643 1.1824 1.2748
BT-20 PD173074
3.33
uM
LJP6
 72
hr
 1657 6371 5383 1.1849 1.2102
Hs 578T Sorafenib
0.12
uM
LJP6
 72
hr
 929 3812 3216 1.1852 1.1991
BT-20 PD173074
1.11
uM
LJP6
 72
hr
 1657 6376 5383 1.1852 1.2109
SK-BR-3 XL147
1.11
uM
LJP5
 72
hr
 1476 4479 3772 1.1871 1.2687
MCF7 HG-6-64-01
0.04
uM
LJP6
 72
hr
 1235 4834 4056 1.1918 1.2152
MCF7 PD173074
3.33
uM
LJP6
 72
hr
 1235 4840 4056 1.1932 1.2169
Hs 578T SB590885
1.11
uM
LJP5
 72
hr
 929 3899 3237 1.2045 1.2177
Hs 578T SB590885
0.04
uM
LJP5
 72
hr
 929 3913 3237 1.2087 1.2219
Hs 578T Sorafenib
3.33
uM
LJP6
 72
hr
 929 3894 3216 1.2107 1.2253
Hs 578T SB590885
3.33
uM
LJP5
 72
hr
 929 3939 3237 1.2167 1.2301
Hs 578T Sorafenib
0.37
uM
LJP6
 72
hr
 929 3923 3216 1.2199 1.2347
BT-20 Enzastaurin
10
uM
LJP5
 72
hr
 1657 6867 5588 1.2290 1.2497
Hs 578T Sorafenib
1.11
uM
LJP6
 72
hr
 929 4060 3216 1.2624 1.2779